Related Experiment Video

Updated: Jul 27, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.7K

Inhibition of Mitochondrial Antioxidant Defense and CDK4/6 in Mesothelioma

Marian Kratzke1, George Scaria1,2,3, Stephen Porter1

  • 1Research Service, Minneapolis VA Health Care System, Minneapolis, MN 55417, USA.

Molecules (Basel, Switzerland)
|June 10, 2023
PubMed

Insights

New research shows auranofin and palbociclib can reduce mesothelioma cell growth. This combination therapy targeting antioxidant defense and cell cycle pathways may offer a novel treatment strategy for advanced mesothelioma.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Advanced mesothelioma is an incurable cancer requiring novel therapeutic approaches.
  • Mitochondrial antioxidant defense and cell cycle pathways are implicated in mesothelioma progression.
  • Targeting these pathways presents a potential strategy for mesothelioma treatment.

Purpose of the Study:

  • To investigate the efficacy of auranofin (antioxidant defense inhibitor) and palbociclib (cyclin-dependent kinase 4/6 inhibitor) in mesothelioma.
  • To evaluate the combined effects of auranofin and palbociclib on mesothelioma cell proliferation and key protein expression.
  • To explore a potential new treatment strategy for advanced mesothelioma.

Main Methods:

  • Assessing the impact of auranofin and palbociclib on mesothelioma cell proliferation in vitro.
  • Analyzing the effects of these drugs on colony growth and cell cycle progression.
  • Quantifying the expression levels of critical antioxidant defense and cell cycle proteins.

Main Results:

  • Both auranofin and palbociclib demonstrated significant reductions in mesothelioma cell proliferation.
  • The drug combination effectively decreased cell growth and inhibited target pathways across all tested assays.
  • Changes in key antioxidant defense and cell cycle protein expression were observed.

Conclusions:

  • Auranofin and palbociclib show promise as a combination therapy for mesothelioma.
  • Inhibition of antioxidant defense and cell cycle pathways is effective against mesothelioma.
  • Further investigation into this drug combination may lead to a new mesothelioma treatment strategy.
Keywords:
antioxidantcell cyclecyclincyclin-dependent kinasemesotheliomamitochondria

More Related Videos

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids10:26

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids

Published on: October 21, 2022

2.0K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K